Literature DB >> 24679741

Prognostic meaning of coronary microvascular disease in type 2 diabetes mellitus: a transthoracic Doppler echocardiographic study.

Lauro Cortigiani1, Fausto Rigo2, Sonia Gherardi3, Maurizio Galderisi4, Francesco Bovenzi1, Rosa Sicari5.   

Abstract

BACKGROUND: The prognostic value of Doppler-derived coronary flow velocity reserve (CFVR) of the left anterior descending coronary artery in patients with type 2 diabetes with preserved left ventricular systolic function and without flow-limiting stenoses on angiography remains undetermined.
METHODS: The study sample consisted of 144 patients with type 2 diabetes (82 men; mean age 62 ± 10 years) with chest pain or angina-equivalent symptoms, no histories of coronary artery disease, and echocardiographic ejection fractions ≥ 50%. All patients underwent dipyridamole stress echocardiography with CFVR assessment of the left anterior descending coronary artery by transthoracic Doppler echocardiography and coronary angiography showing normal coronary arteries or nonobstructive coronary artery disease.
RESULTS: Mean CFVR was 2.44 ± 0.57. On individual patient analysis, 109 patients (76%) had CFVR > 2, and 35 (24%) had CFVR ≤ 2. During a median follow-up period of 29 months (interquartile range, 14-44 months), 17 hard events (five deaths, 12 nonfatal myocardial infarctions) occurred. The annual hard-event rate was 13.9% in subjects with CFVR ≤ 2 and 2.0% in those with CFVR > 2. The annual event rate associated with CFVR ≤ 2 was significantly higher both in patients with left ventricular hypertrophy (P < .0001) and in those without left ventricular hypertrophy (P = .048). On Cox analysis, CFVR ≤ 2 (hazard ratio, 11.20; 95% confidence interval, 3.07-40.92), and male sex (hazard ratio, 7.80; 95% confidence interval, 1.74-34.97) were independent prognostic indicators, whereas nonobstructive coronary artery disease was not an independent predictor of outcomes.
CONCLUSIONS: Microvascular dysfunction before the occurrence of coronary artery involvement is a strong and independent predictor of outcomes in patients with type 2 diabetes. Vasodilator stress CFVR is a suitable tool to assess microvascular dysfunction in routine clinical practice.
Copyright © 2014 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Coronary flow velocity reserve; Diabetes; Microvascular disease; Prognosis; Vasodilator stress echocardiography

Mesh:

Year:  2014        PMID: 24679741     DOI: 10.1016/j.echo.2014.02.010

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  20 in total

Review 1.  Coronary Flow Velocity Reserve Assessment with Transthoracic Doppler Echocardiography.

Authors:  Iana Simova
Journal:  Eur Cardiol       Date:  2015-07

2.  Human Mesenchymal Stem Cell Delivery System Modulates Ischemic Cardiac Remodeling With an Increase of Coronary Artery Blood Flow.

Authors:  Young Sook Lee; Wan Seok Joo; Hyun Soo Kim; Sung Wan Kim
Journal:  Mol Ther       Date:  2016-01-19       Impact factor: 11.454

3.  CHADS2, CHA2DS2-VASc and R2CHADS2 scores predict mortality in patients with coronary artery disease.

Authors:  Fang-Yang Huang; Bao-Tao Huang; Xiao-Bo Pu; Yong Yang; Shi-Jian Chen; Tian-Li Xia; Yi-Yue Gui; Yong Peng; Rui-Shuang Liu; Yuanweixiang Ou; Fei Chen; Ye Zhu; Mao Chen
Journal:  Intern Emerg Med       Date:  2017-02-04       Impact factor: 3.397

Review 4.  Coronary microvascular dysfunction in diabetes mellitus.

Authors:  Aleksandar Kibel; Kristina Selthofer-Relatic; Ines Drenjancevic; Tatjana Bacun; Ivica Bosnjak; Dijana Kibel; Mario Gros
Journal:  J Int Med Res       Date:  2017-01-12       Impact factor: 1.671

Review 5.  Assessment and Treatment for Coronary Microvascular Dysfunction by Contrast Enhanced Ultrasound.

Authors:  Junzhen Zhan; Longhe Zhong; Juefei Wu
Journal:  Front Cardiovasc Med       Date:  2022-06-20

Review 6.  Revascularization Strategies in Patients with Diabetes Mellitus and Acute Coronary Syndrome.

Authors:  Adam J Buntaine; Binita Shah; Jeffrey D Lorin; Steven P Sedlis
Journal:  Curr Cardiol Rep       Date:  2016-08       Impact factor: 2.931

7.  Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes - a randomized, single-blinded, cross-over pilot study.

Authors:  Rebekka Faber; Mette Zander; Adam Pena; Marie M Michelsen; Naja D Mygind; Eva Prescott
Journal:  Cardiovasc Diabetol       Date:  2015-04-22       Impact factor: 9.951

8.  The prognostic role of stress echocardiography in a contemporary population and the clinical significance of limited apical ischaemia.

Authors:  Alexandros Papachristidis; Damian Roper; Daniela Cassar Demarco; Ioannis Tsironis; Michael Papitsas; Jonathan Byrne; Khaled Alfakih; Mark J Monaghan
Journal:  Echo Res Pract       Date:  2016-11-21

9.  Guidelines for reasonable and appropriate care in the emergency department (GRACE): Recurrent, low-risk chest pain in the emergency department.

Authors:  Paul I Musey; Fernanda Bellolio; Suneel Upadhye; Anna Marie Chang; Deborah B Diercks; Michael Gottlieb; Erik P Hess; Michael C Kontos; Bryn E Mumma; Marc A Probst; John H Stahl; Jason P Stopyra; Jeffrey A Kline; Christopher R Carpenter
Journal:  Acad Emerg Med       Date:  2021-07-06       Impact factor: 5.221

10.  Prognostic value of calcium score and coronary flow velocity reserve in asymptomatic diabetic patients.

Authors:  Miodrag Dikic; Milorad Tesic; Zeljko Markovic; Vojislav Giga; Ana Djordjevic-Dikic; Jelena Stepanovic; Branko Beleslin; Ivana Jovanovic; Ana Mladenovic; Jelena Seferovic; Miodrag Ostojic; Aleksandra Arandjelovic
Journal:  Cardiovasc Ultrasound       Date:  2015-09-04       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.